‘Mylan must be held accountable’: why a generic EpiPen could prevent a cheaper product in the long term

The CEO called it an “extraordinary” move. But companies do it all the time.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.